National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 4) (No. PB 58 of 2013) (Cth)

PB 58 of 2013

National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 4)

National Health Act 1953

I, GREG O’TOOLE, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the

Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                   14        August 2013

GREG O’TOOLE

Assistant Secretary (Acting)

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 4).

(2)   This Determination may also be cited as PB 58 of 2013.

1. Commencement

This Determination commences on 1 September 2013.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Tadalafil

Insert

Tafluprost